PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1007.72%
Some net income increase while BB is negative at -314.40%. John Neff would see a short-term edge over the struggling competitor.
-10.92%
Negative yoy D&A while BB is 23.39%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-94.35%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
15.96%
SBC growth while BB is negative at -26.47%. John Neff would see competitor possibly controlling share issuance more tightly.
22.45%
Slight usage while BB is negative at -5.73%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
222.95%
AR growth while BB is negative at -41.06%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-279.85%
Negative yoy inventory while BB is 106.92%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-262.46%
Negative yoy AP while BB is 53.25%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-53.23%
Negative yoy usage while BB is 67.24%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-171.12%
Negative yoy while BB is 0.58%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
10.51%
Some CFO growth while BB is negative at -32.29%. John Neff would note a short-term liquidity lead over the competitor.
3.05%
Lower CapEx growth vs. BB's 64.41%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-117.68%
Both yoy lines negative, with BB at -110.11%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-68.48%
Both yoy lines negative, with BB at -16.56%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
64.85%
Proceeds from sales/maturities above 1.5x BB's 37.76%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-0.50%
We reduce yoy other investing while BB is 100.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-65.57%
Both yoy lines negative, with BB at -16.23%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
125.50%
Issuance growth of 125.50% while BB is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-58.45%
We cut yoy buybacks while BB is 100.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.